Paid Clinical Trials in Duarte, CA

As of August 2026, 538 paid clinical trials are recruiting in Duarte, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 10, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

501 clinical trials

A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

for Squamous Cell Carcinoma of Head and Neck

Sites in Duarte, La Jolla +8 more locations

Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All·Age: 18 - 74

Code: NCT07219212·Phase 1·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

for Solid Tumors

Sites in Duarte, La Jolla +6 more locations

Sponsor: Incyte Corporation

Sex: All·Age: 18+

Code: NCT07195916·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors

for Advanced Squamous Tumors

Sites in Duarte, Irvine +4 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT07241039·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

for Non-Hodgkin Lymphoma Refractory/ Relapsed

Sites in Duarte +5 more locations

Sponsor: LTZ Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07121946·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

for Advanced Solid Tumors

Sites in Duarte, Newport Beach +4 more locations

Sponsor: SEED Therapeutics, Inc.

Sex: All·Age: 16+

Code: NCT07197554·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

for Metastatic Hepatocellular Carcinoma

Drug: Bevacizumab

Sites in Duarte +6 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06427941·Phase 1·Recruiting·Listed May 2024

Apply to this trial

Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia

for Waldenstrom Macroglobulinemia

Sites in Duarte, Glendale +4 more locations

Sponsor: BeiGene

Sex: All·Age: 18+

Code: NCT05640102·Recruiting·Listed Dec 2022

Apply to this trial

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

for B-cell Acute Lymphoblastic Leukemia

Sites in Duarte, Los Angeles +9 more locations

Sponsor: Vironexis Biotherapeutics Inc.

Sex: All·Age: 13 - 90

Code: NCT06533579·Phase 1, Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Duarte, Los Angeles +11 more locations

Sponsor: Vividion Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06004245·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

A Study of BG-C477 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Duarte +8 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06596473·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

for Relapsed or Refractory Multiple Myeloma

Sites in Duarte, Irvine +7 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT05652335·Phase 1·Recruiting·Listed Dec 2022

Apply to this trial

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

for Relapsed/Refractory Systemic Light Chain Amyloidosis

Drug: Linvoseltamab

Sites in Duarte +7 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06292780·Phase 1, Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

for Multiple Myeloma

Sites in Duarte, Irvine +12 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT06892522·Phase 1, Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer

for Hepatocellular Carcinoma

Sites in Duarte +1 more location

Sponsor: Bayer

Sex: All·Age: 18+

Code: NCT06764316·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

for Advanced Metastatic Castration-resistant Prostate Cancer

Sites in Duarte +3 more locations

Sponsor: Bayer

Sex: All·Age: 18+

Code: NCT06217822·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

for Hepatocellular Carcinoma

Sites in Duarte +4 more locations

Sponsor: Eureka Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT04864054·Phase 1, Phase 2·Recruiting·Listed Apr 2021

Apply to this trial

First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations

for Non-Small Cell Lung Cancer

Sites in Duarte, Huntington Beach +7 more locations

Sponsor: Pierre Fabre Medicament

Sex: All·Age: 18+

Code: NCT06043817·Phase 1, Phase 2·Recruiting·Listed Sep 2023

Apply to this trial

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

for Multiple Myeloma in Relapse

Sites in Duarte, Palo Alto +5 more locations

Sponsor: Kelonia Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07075185·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease

for Refractory Metastatic Colorectal Cancer

Sites in Duarte, Santa Monica +4 more locations

Sponsor: Delcath Systems Inc.

Sex: All·Age: 18+

Code: NCT06607458·Phase 2·Recruiting·Listed Sep 2024

Apply to this trial

LYL273 for Patients With Relapsed or Refractory mCRC

for Colorectal Cancer

Sites in Duarte, San Francisco +2 more locations

Sponsor: Lyell Immunopharma, Inc.

Sex: All·Age: 18+

Code: NCT05319314·Phase 1, Phase 2·Recruiting·Listed Apr 2022

Apply to this trial

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Duarte, Los Angeles +7 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT05981703·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

for Unresectable

Sites in Duarte +2 more locations

Sponsor: Recursion Pharmaceuticals Inc.

Sex: All·Age: 12+

Code: NCT06678659·Phase 1, Phase 2·Recruiting·Listed Nov 2024

Apply to this trial

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

for Lymphoma, B-Cell

Sites in Duarte +5 more locations

Sponsor: Umoja Biopharma

Sex: All·Age: 18+

Code: NCT06528301·Phase 1·Recruiting·Listed Jul 2024

Apply to this trial

Study With [225Ac]Ac-FL-020 in mCRPC Participants

for Metastatic Castration-resistant Prostate Cancer

Sites in Duarte, Irvine +3 more locations

Sponsor: Full-Life Technologies UK Limited

Sex: Male·Age: 18+

Code: NCT06492122·Phase 1·Recruiting·Listed Jul 2024

Apply to this trial

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)

for Neoplasms

Sites in Duarte +5 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT06884618·Phase 1·Recruiting·Listed Mar 2025

Apply to this trial

A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

for B-cell Non-Hodgkins Lymphoma (B-NHL)

Drug: Odronextamab

Sites in Duarte, Santa Monica +7 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT05685173·Phase 1·Recruiting·Listed Jan 2023

Apply to this trial

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

for CTCL

Sites in Duarte, Irvine +4 more locations

Sponsor: Prescient Therapeutics, Ltd.

Sex: All·Age: 18+

Code: NCT06854653·Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.

for Locally Advanced Pancreatic Adenocarcinoma

Sites in Duarte, Irvine +2 more locations

Sponsor: Xerient Pharma

Sex: All·Age: 18+

Code: NCT07157033·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

for Acute Myeloid Leukemia

Sites in Duarte +6 more locations

Sponsor: Debiopharm International SA

Sex: All·Age: 18+

Code: NCT06969430·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

for Lymphoma

Sites in Duarte +3 more locations

Sponsor: VIVUS LLC

Sex: All·Age: 18+

Code: NCT06915246·Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer

for Ovarian Cancer

1 location in Duarte

Sponsor: PhotonPharma, Inc.

Sex: Female·Age: 18+

Code: NCT06366490·Phase 1·Recruiting·Listed Apr 2024

Apply to this trial

A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

for Myelofibrosis

Drug: Selinexor

Sites in Duarte +6 more locations

Sponsor: Karyopharm Therapeutics Inc

Sex: All·Age: 18+

Code: NCT05980806·Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers

for Oral Squamous Cell Carcinoma

Sites in Duarte +3 more locations

Sponsor: Privo Technologies

Sex: All·Age: 18 - 100

Code: NCT05893888·Phase 2, Phase 3·Recruiting·Listed Jun 2023

Apply to this trial

A Study of KK2269 in Adult Participants With Solid Tumors

for Advanced Solid Tumor

Sites in Duarte, Newport Beach +5 more locations

Sponsor: Kyowa Kirin Co., Ltd.

Sex: All·Age: 18+

Code: NCT06266299·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

for Advanced Malignancies

Sites in Duarte +2 more locations

Sponsor: BioInvent International AB

Sex: All·Age: 18+

Code: NCT04752826·Phase 1, Phase 2·Recruiting·Listed Feb 2021

Apply to this trial

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With Myelofibrosis

for Myelofibrosis

Drug: Ruxolitinib

Sites in Duarte, Irvine +4 more locations

Sponsor: Geron Corporation

Sex: All·Age: 18+

Code: NCT05371964·Phase 1·Recruiting·Listed May 2022

Apply to this trial

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

for Advanced/Metastatic Solid Tumors

Sites in Duarte, Irvine +4 more locations

Sponsor: Adagene Inc

Sex: All·Age: 18+

Code: NCT05405595·Phase 1, Phase 2·Recruiting·Listed Jun 2022

Apply to this trial

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

for Myelodysplastic Syndromes

Sites in Duarte +2 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT04419649·Phase 2·Recruiting·Listed Jun 2020

Apply to this trial

A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

for Triple Negative Breast Cancer

Sites in Duarte, La Jolla +4 more locations

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.

Sex: All·Age: 18+

Code: NCT06908928·Phase 1·Recruiting·Listed Apr 2025

Apply to this trial

BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

for Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Sites in Duarte, Stanford +4 more locations

Sponsor: PeproMene Bio, Inc.

Sex: All·Age: 18+

Code: NCT05370430·Phase 1·Recruiting·Listed May 2022

Apply to this trial